Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Reports of Patients and Relatives from the CogniCIS Study about Cognition in Clinically Isolated Syndrome: What Are Our Patients Telling Us?
Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
CD226 Gly307Ser Association With Neuromyelitis Optica in Southern Han Chinese.
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors b20-4.1.1 and angiostatin (k1-3).
Central and peripheral demyelination.
Interferon beta-1a for multiple sclerosis: old drug, new clothes.
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
Self-intermittent catheterization in multiple sclerosis.
Spousal support as experienced by people with multiple sclerosis: a qualitative study.
Upper limb functional electrical stimulation devices and their man-machine interfaces.
The psychosocial difficulties in brain disorders that explain short term changes in health outcomes.
A Qualitative Study Exploring the Usability of Nintendo Wii Fit among Persons with Multiple Sclerosis.
Computer-based diagnosis of illness in historical persons.
RECENT ADVANCES IN MESENCHYMAL STEM CELL IMMUNOMODULATION. THE ROLE OF MICROVESICLES.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Cortical and leptomeningeal involvement in three cases of neuromyelitis optica.
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time.
Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.
Interview: Experiences targeting B cells for the treatment of multiple sclerosis.
Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.
Pages
« first
‹ previous
…
353
354
355
356
357
358
359
360
361
…
next ›
last »